Correction: Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in November
November 10 2016 - 9:36AM
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that
senior leadership is scheduled to present an overview of the
company at the following investor conferences in November:
- Jefferies 2016 London Healthcare Conference at 2:00 p.m. GMT
(9:00 a.m. ET) in London on Thursday, November 17, 2016.
- 28th Annual Piper Jaffray Healthcare Conference at 11:00 a.m.
ET in New York on Tuesday, November 29, 2016.
Live audio webcasts of the Pacira presentations can be accessed
by visiting the “Investors & Media” section of the company’s
website at investor.pacira.com. Replays of the webcasts will be
archived on the Pacira website for two weeks following the
respective presentation dates.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated
for single-dose infiltration into the surgical site to produce
postsurgical analgesia, was commercially launched in the United
States in April 2012. EXPAREL and two other products have
successfully utilized DepoFoam®, a unique and proprietary product
delivery technology that encapsulates drugs without altering their
molecular structure, and releases them over a desired period of
time. Additional information about Pacira is available at
www.pacira.com.
Company Contact:
Pacira Pharmaceuticals, Inc.
Jessica Cho, (973) 254-3574
jessica.cho@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Apr 2024 to May 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From May 2023 to May 2024